These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review. Da Cunha T, Vaziri H. J Clin Gastroenterol; 2024 Jan 01; 58(1):1-11. PubMed ID: 37548445 [Abstract] [Full Text] [Related]
24. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Broomé U, Löfberg R, Lundqvist K, Veress B. Dis Colon Rectum; 1995 Dec 01; 38(12):1301-5. PubMed ID: 7497843 [Abstract] [Full Text] [Related]
25. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk? Breynaert C, Vermeire S, Rutgeerts P, Van Assche G. Acta Gastroenterol Belg; 2008 Dec 01; 71(4):367-72. PubMed ID: 19317276 [Abstract] [Full Text] [Related]
26. Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence. Burke KE, Nayor J, Campbell EJ, Ananthakrishnan AN, Khalili H, Richter JM. Dig Dis Sci; 2020 Jan 01; 65(1):111-118. PubMed ID: 31367882 [Abstract] [Full Text] [Related]
27. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease. Aalykke C, Jensen MD, Fallingborg J, Jess T, Langholz E, Meisner S, Andersen NN, Riis LB, Thomsen OØ, Tøttrup A. Dan Med J; 2015 Jan 01; 62(1):B4995. PubMed ID: 25557336 [Abstract] [Full Text] [Related]
28. Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Rao BB, Lashner B, Kowdley KV. Inflamm Bowel Dis; 2018 Jan 18; 24(2):269-276. PubMed ID: 29361103 [Abstract] [Full Text] [Related]
31. Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis. El-Matary W, Guthery SL, Amir AZ, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Hochberg JT, Horslen S, Kerkar N, Koot BGP, Laborda TJ, Loomes KM, Mack C, Martinez M, Miethke A, Miloh T, Mogul D, Mohammed S, Moroz S, Ovchinsky N, Perito ER, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Soufi N, Valentino PL, Zizzo A, Deneau MR. Clin Gastroenterol Hepatol; 2021 May 18; 19(5):1067-1070.e2. PubMed ID: 32360820 [Abstract] [Full Text] [Related]
32. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. Lutgens M, Vermeire S, Van Oijen M, Vleggaar F, Siersema P, van Assche G, Rutgeerts P, Oldenburg B, Dutch Initiative on Crohn and Colitis. Clin Gastroenterol Hepatol; 2015 Jan 18; 13(1):148-54.e1. PubMed ID: 25041864 [Abstract] [Full Text] [Related]
33. Colorectal Cancer Screening in Inflammatory Bowel Disease. Sengupta N, Yee E, Feuerstein JD. Dig Dis Sci; 2016 Apr 18; 61(4):980-9. PubMed ID: 26646250 [Abstract] [Full Text] [Related]